Dementia associated with Parkinson's disease is characterized by a decline in cognitive functions such as memory, executive function, and visuospatial abilities. The presence of dementia in Parkinson's is linked to a more rapid progression of the disease and increased mortality. Current research is dedicated to identifying biomarkers for the early detection of Parkinson's dementia and developing targeted therapies to prevent or slow down cognitive decline.
In the case of Huntington's disease, dementia is marked by a decline in executive function, language, and behavior. The presence of dementia in Huntington's is associated with a more severe motor phenotype and increased disability. Ongoing research is focused on understanding the role of the huntingtin protein in cognitive decline and devising neuroprotective therapies to mitigate the progression of Huntington's dementia.
The Alzheimer's 2024 conference is anticipated to be a pivotal event in the realm of neurodegenerative dementia research, offering fresh perspectives and optimism for advancements in the diagnosis, treatment, and prevention of both Parkinson's and Huntington's dementia.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
